Stay updated on Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.

Latest updates to the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded related topic tag: Multiple myeloma and a MedlinePlus Genetics link. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedAncillary items such as the government funding notice and related topics (e.g., MedlinePlus Genetics) were removed from the page, and this does not affect the study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check27 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and added 'MedlinePlus Genetics' as a related topic on the study page.SummaryDifference0.1%

- Check41 days agoChange DetectedThe new screenshot shows removal of the 'Multiple myeloma' item from related topics and the 'MedlinePlus Genetics' entry in related topics.SummaryDifference0.3%

- Check48 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma; this reduces coverage of a notable medical condition in the genetics section.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a MedlinePlus Genetics topic covering Multiple myeloma, expanding core content and proper noun coverage.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Newly Diagnosed Multiple Myeloma Clinical Trial page.